Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
fulvia.ceccarelli@uniroma1.it
Fulvia Ceccarelli
Assegnista di ricerca
Struttura:
DIPARTIMENTO DI SCIENZE CLINICHE INTERNISTICHE, ANESTESIOLOGICHE E CARDIOVASCOLARI
E-mail:
fulvia.ceccarelli@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Clinical, histologic, and immunologic signatures of Small Fiber Neuropathy in Systemic Lupus Erythematosus
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
2024
Evidence of immune response to BNT162b2 COVID-19 vaccine in systemic lupus erythematosus patients treated with Belimumab
LUPUS
2023
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach
CANCER IMMUNOLOGY, IMMUNOTHERAPY
2023
Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity
JOURNAL OF IMMUNOLOGY RESEARCH
2023
Effectiveness of non-medical switch from adalimumab bio-originator to SB5 biosimilar and from ABP501 adalimumab biosimilar to SB5 biosimilar in patients with chronic inflammatory arthropathies: a monocentric observational study
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2023
Application of Machine Learning Models in Systemic Lupus Erythematosus
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2023
Organ damage in Systemic Lupus Erythematosus patients: A multifactorial phenomenon
AUTOIMMUNITY REVIEWS
2023
Rheumatic Diseases Development in Patients Treated by Anti-PD1 Immune Checkpoint Inhibitors: A Single-Centre Descriptive Study
LIFE
2023
Early and late response and glucocorticoid-sparing effect of belimumab in patients with systemic lupus erythematosus with joint and skin manifestations. results from the belimumab in real life setting study-joint and skin (BeRLiSS-JS)
JOURNAL OF PERSONALIZED MEDICINE
2023
Fragility fractures in lupus patients:. associated factors and comparison of four fracture risk assessment tools
LUPUS
2023
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib.
SCIENTIFIC REPORTS
2023
Organ damage in systemic lupus erythematosus patients. a multifactorial phenomenon
AUTOIMMUNITY REVIEWS
2023
Exercise-induced modulation of Interferon-signature. a therapeutic route toward management of systemic lupus erythematosus
AUTOIMMUNITY REVIEWS
2023
KLRG1 is reduced on NK cells in SLE patients, inversely correlates with disease activity and is modulated by hydroxychloroquine in vitro
LUPUS
2023
Belimumab decreases autophagy and citrullination in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
CELLS
2022
Porphyromonas gingivalis amount in the tongue biofilm is associated with erosive arthritis in systemic lupus erythematosus
LUPUS
2022
Development of Systemic Autoimmune Diseases in Healthy Subjects Persistently Positive for Antiphospholipid Antibodies: Long-Term Follow-Up Study
BIOMOLECULES
2022
Relationship Between Gender Differences and Clinical Outcome in Patients With the Antiphospholipid Syndrome
FRONTIERS IN IMMUNOLOGY
2022
Autophagy Hijacking in PBMC From COVID-19 Patients Results in Lymphopenia
FRONTIERS IN IMMUNOLOGY
2022
Are interferon-gamma release assays reliable to detect tuberculosis infection in patients with rheumatoid arthritis treated with Janus kinase inhibitors?
PLOS ONE
2022
1
2
3
4
5
6
7
seguente ›
ultima »
Progetti di Ricerca
CONTRIBUTO DEI FATTORI GENETICI NELLO SVILUPPO DEL DANNO CRONICO IN PAZIENTI AFFETTI DA LUPUS ERITEMATOSO SISTEMICO
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma